Browse by Medical Category
Bob S. Carter, MD, is a board-certified neurosurgeon who specializes in brain tumors, vascular lesions and complex intracranial surgery, including cerebral bypass and aneurysm surgery. He is one of the nation’s leading clinical neurosurgeons and a prolific academic teacher and researcher.
Dr. Carter co-leads MGH’s brain tumor program, which brings together the efforts of over 100 faculty and staff who are focused on brain tumor clinical care, research and education. He is the Chair of the Department of Neurosurgery at MGH and Visiting Professor at Harvard Medical School.
Dr. Carter's scientific work has included the development of the first reported EGFRvIII directed CAR T-cell therapy, and the first characterizations of exosomes in glioblastoma. He is a Principal Investigator participating in the NIH funded Extracellular RNA Communication Consortium. Dr. Carter leads a team of clinician scientists who have developed the role of 'big data' in characterizing outcomes in oncologic and vascular neurosurgery.
Dr. Carter is extensively published and his work has been cited more than 15,000 times in the scientific literature. He lectures both nationally and internationally on neurosurgery topics and is an editorial board member for the Journal of Neurosurgery and editorial advisory board member for Neurosurgery.
Prior to joining MGH, Dr. Carter served as Professor and Chair of Neurosurgery at the UC San Diego School of Medicine.
He completed his neurosurgery residency at Massachusetts General Hospital and his post-doctoral fellowship with Dr. Richard Mulligan at the Whitehead Institute, MIT in Cambridge, Massachusetts. Dr. Carter earned his medical degree from the Johns Hopkins School of Medicine and his PhD in genetic epidemiology from the Johns Hopkins Bloomberg School of Public Health. He is board-certified in neurological surgery.
Dr. Carter is a fellow of the American Association of Neurological Surgeons and a member of numerous medical organizations, including the Congress of Neurological Surgeons, the American Academy of Neurological Surgery and the Society of Neurological Surgeons. He serves on the program committee for the American Stroke Association’s International Stroke Conference and has served on the executive boards of the Joint Cerebrovascular Section, the New England Neurosurgical Society and the California Association of Neurological Surgeons.
He is consistently elected to Castle Connolly, America's Top Doctors® and was consistently one of San Diego’s Top Docs in the San Diego Magazine “Physicians of Exceptional Excellence” survey.